Measles: The need for 2 opportunities for prevention

Clinical Infectious Diseases

Volumn 42, Issue 3, 2006, Pages 320-321

  Orenstein, Walter A ^a   Hinman, Alan R ^b   Strebel, Peter J ^c  

^a EMORY UNIVERSITY   (United States)

^b Task Force for Child Survival and Development   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MEASLES VACCINE;

CROWDING; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; ERADICATION THERAPY; HERD IMMUNITY; HUMAN; MEASLES; MEASLES VACCINATION; MORTALITY; NOTE; PRIORITY JOURNAL; SEROCONVERSION; UNITED STATES; VIRUS TRANSMISSION;

DISEASE OUTBREAKS; DRUG ADMINISTRATION SCHEDULE; HUMANS; MEASLES; MEASLES VACCINE; POPULATION DENSITY; RISK FACTORS; WORLD HEALTH;

EID: 31044432818     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/498321     Document Type: Note

References (10)

1. World Health Organization. Progress in reducing global measles deaths: 1999-2003. Wkly Epidemiol Rec 2005; 80:78-81.
2. Hinman AR, Orenstein WA, Papania MJ. Evolution of measles elimination strategies in the United States. J Infect Dis 2004; 189(Suppl 1): S17-22.
3. Orenstein WA, Strebel PM, Papania M, et al. Measles eradication: is it in our future? Am J Public Health 2000; 90:1521-5.
4. Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis 2003; 187(Suppl 1):S283-90.
5. Fine PE. Community immunity. In: Plotkin S, Orenstein W, eds. Vaccines. 4th ed. Philadelphia: Elsevier, 2004:1443-61.
6. King GE, Markowitz LE, Patriarca PA, et al. Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J 1991; 10:883-8.
7. Katz SL, Hinman AK. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis 2004; 189(Suppl 1): S43-7.
8. Marin M, Nguyen HQ, Langidrik JR, et al. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clin Infect Dis 2006; 42:315-9 (in this issue).
9. Strebel P, Papania M, Halsey N. Measles vaccine. In: Plotkin S, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia: Elsevier, 2004:389-440.
10. de Quadros CA, Olive JM, Hersh BS, et al. Measles elimination in the Americas: evolving strategies. JAMA 1996; 275:224-9.